Keurig Dr Pepper (KDP) Earnings Analysis

Keurig Dr Pepper (KDP) delivered mixed results in FY2026 on revenue of $139.5B versus the $137.6B estimate (-3.7% YoY) and EPS of $2.08. Below is the full Keurig Dr Pepper earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Keurig Dr Pepper (KDP) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$139.5B (vs $137.6B est · +1.4% surprise · -3.7% YoY)
EPS$2.08 (vs $1.99 est · +4.5% surprise · +21.6% YoY)
Share price$321.21 (+1.1%)
Market cap$840.0B

What you'll find

Frequently asked questions

When is Keurig Dr Pepper's next earnings date?
Keurig Dr Pepper's (KDP) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Keurig Dr Pepper (KDP) beat or miss earnings?
In FY2026, Keurig Dr Pepper (KDP) posted mixed results — revenue of $139.5B versus the $137.6B estimate (+1.4% surprise) and EPS of $2.08 versus $1.99 expected (+4.5% surprise). Magnisto decodes every Keurig Dr Pepper (KDP) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Keurig Dr Pepper (KDP) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Keurig Dr Pepper (KDP), anchored to the current $321.21 share price, so you can weigh the bull, base and bear cases for Keurig Dr Pepper side by side.
Is Keurig Dr Pepper (KDP) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Keurig Dr Pepper fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.